Jenburkt Pharmaceuticals Ltd.
BSE: 524731
₹1,147.05
₹-8.85
(-0.77%)
As on 21-May-2026IST
Market cap
₹506 Cr
Revenue (TTM)
₹169 Cr
P/E Ratio
14.6
P/B Ratio
2.6
Div. Yield
0 %
Quality Score
9/10
Growth Score
7/10
Valuation Score
6/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹35 Cr
-
ROE
20.2 %
-
ROCE
27.9 %
-
Industry P/E
44.31
-
EV/EBITDA
8.4
-
Debt to Equity
0
-
Book Value
₹446.5
-
EPS
₹85.8
-
Face value
10
-
Shares outstanding
4,413,300
10 Years Aggregate
CFO
₹143.76 Cr
EBITDA
₹255.61 Cr
Net Profit
₹197.61 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Jenburkt Pharma
| 5.3 | 9.2 | 11.8 | 1.4 | 16.2 | 19.1 | 9.8 |
|
BSE Healthcare
| 10.2 | 10.3 | 11.1 | 13.4 | 28.1 | 14.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Jenburkt Pharma
| -10.7 | 79.0 | 4.6 | 22.0 | 26.0 | 8.7 | -30.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Jenburkt Pharma
|
1,147.1 | 506.2 | 168.7 | 34.7 | 24.1 | 19.9 | 14.6 | 2.6 |
| 3,000.4 | 24,554.0 | 1,339.4 | 356.4 | 33.2 | 23.2 | 68.9 | 14.8 | |
| 521.4 | 8,201.8 | 4,359.0 | 256.4 | 8.4 | 8.3 | 32.1 | 2.5 | |
| 748.9 | 14,696.0 | 7,344.9 | 670.6 | 10.9 | 13.7 | 21.8 | 2.6 | |
| 419.9 | 16,087.0 | 2,268.6 | 150.1 | 10.6 | 5.4 | 89.8 | 4.1 | |
| 764.2 | 18,926.7 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.8 | 3.7 | |
| 1,861.8 | 21,346.5 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.7 | |
| 176.1 | 23,381.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 470.2 | 18,982.5 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.9 | 3.9 | |
| 1,599.8 | 26,016.6 | 3,373.0 | 199.0 | 12.6 | 5.9 | 122.1 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Jenburkt Pharma
Jenburkt Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical formulations primarily in India. It offers products in various therapeutic areas, such as pain management, neuropathic pain, anthelmintics, analgesics and... antipyretics, anti-arthritic, anti-diabetic, anti-infective, anti-fungal, anti-malarial, anti-ulcerant/antacid, aphrodisiac, cough and cold, and muscle relaxants, as well as nutraceutical and consumer products. The company provides its products through stockists and super stockists to doctors, chemists, large government and semi-government institutions, missionary hospitals, public sector enterprises, etc. It also exports its products to approximately 13 countries. The company was founded in 1985 and is based in Mumbai, India. Read more
-
Incorporated
1985
-
Chairman
Ashish U Bhuta
-
Managing Director
Ashish U Bhuta
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Jenburkt Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Jenburkt Pharma
What is the current share price of Jenburkt Pharmaceuticals Ltd Today?
The share price of Jenburkt Pharmaceuticals Ltd is ₹1,147.05 (BSE) as of 21-May-2026 IST. Jenburkt Pharmaceuticals Ltd has given a return of 16.21% in the last 3 years.
What is the current PB & PE ratio of Jenburkt Pharmaceuticals Ltd?
The P/E ratio of Jenburkt Pharmaceuticals Ltd is 14.57 times as on 21-May-2026, a 67 discount to its peers’ median range of 44.31 times.
The P/B ratio of Jenburkt Pharmaceuticals Ltd is 2.57 times as on 21-May-2026, a 34 discount to its peers’ median range of 3.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.93
|
2.60
|
|
2024
|
11.71
|
2.10
|
|
2023
|
11.94
|
2.40
|
|
2022
|
11.66
|
2.22
|
|
2021
|
11.08
|
1.86
|
What is the 52 Week High and Low of Jenburkt Pharmaceuticals Ltd?
The 52-week high and low of Jenburkt Pharmaceuticals Ltd are Rs 1,410.00 and Rs 944.00 as of 21-May-2026.
What is the market cap of Jenburkt Pharmaceuticals Ltd?
Jenburkt Pharmaceuticals Ltd has a market capitalisation of ₹ 506 Cr as on 21-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Jenburkt Pharmaceuticals Ltd?
Before investing in Jenburkt Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.